A Multi-center, Randomized, Double-Blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DWJ1451 in Patients With Hypertension and Dyslipidemia
Latest Information Update: 04 Feb 2022
At a glance
- Drugs Amlodipine/olmesartan/ezetimibe/rosuvastatin (Primary) ; Ezetimibe/rosuvastatin; Olmesartan medoxomil; Olmesartan medoxomil/amlodipine
- Indications Dyslipidaemias; Hyperlipidaemia; Hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Daewoong Pharmaceutical
- 07 Apr 2021 New trial record